Clinical trial
Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00004937 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00004937 |
|---|---|
| Title | Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme |
| Official title | Open Label Phase II Study on XR5000 Administered as a 5 Day Infusion in Patients With Glioblastoma Multiforme |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | acridine carboxamide |
| Start date | Oct 1, 1999 |
| Primary completion | May 1, 2000 |
| First posted | Aug 9, 2004 |
| Last update posted | Jul 11, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: